Sandhoff Disease Market Insights — Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the development

  • Sandhoff disease is a rare disorder that affects around 1 in 1,000,000 individuals
  • Sandhoff’s illness was first discovered in Germany in 1965 by Drs. Horst Jatzkewitz, Hartmut Pilz, and Konrad Sandhoff
  • The prevalence of Sandhoff disease is most common in Northern Argentina and Canada
  • Abnormal bone development
  • Awkward movements
  • Red spots in the eyeballs
  • Enlarged head
  • Enlarged internal body organs
  • venglustat GZ402671
  • IB1001
  • Pyrimethamine
  • Zavesca
  • Sanofi
  • Genzyme
  • IntraBio Inc
  • Idorsia Pharmaceuticals

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store